Close Menu

chlamydia

NEW YORK (GenomeWeb) ― In the first update since 2007, the US Preventative Services Task Force recently provided new guidelines to clinicians for chlamydia and gonorrhea screening.

NEW YORK (GenomeWeb) — Becton Dickinson executives this week updated investors on its molecular diagnostics sales and development pipeline, and provided a window into the company's plans for GenCell, the next-generation sequencing sample prep firm it acquired last month.

NEW YORK (GenomeWeb) — Cepheid said last week that its third quarter revenues grew 15 percent year over year driven primarily by stronger than expected commercial clinical revenue resulting from new Xpert assays and customer types.

NEW YORK (GenomeWeb) — Bay Area startup Diassess has been awarded nearly $300,000 from the National Institutes of Health for the first year of a two-year project to develop a point-of-care, nucleic acid amplification-based diagnostic device for sexually transmitted infections, with an initial foc

NEW YORK (GenomeWeb) – Hologic said after the close of the market on Wednesday that its revenues for the fiscal third quarter inched up 1 percent year over year.

NEW YORK (GenomeWeb) – The University of Maryland's Schools of Dentistry and Medicine said today they have jointly received a $10.7 million grant from the National Institute of Allergy and Infectious Diseases to use omics methods to identify molecular biomarkers related to sexually transmitted in

NEW YORK (GenomeWeb) – BD Diagnostics said today the US Food and Drug Administration has cleared for marketing the BD ProbeTec Chlamydia trachomatis Qx Amplified DNA Assay and the BD ProbeTec Neisseria gonorrhea Qx Amplified DNA Assay on the BD Viper LT system.

NEW YORK (GenomeWeb) – Atlas Genetics today announced it completed the final tranche of its £16.9 million ($28.4 million) Series B financing to complete the transfer to manufacture of its io molecular diagnostics system and file for regulatory approval of the first test for chlamydia.

Molecular diagnostic company Wave 80 Biosciences has received Phase I Small Business Innovation Research funding from the National Institutes of Health to develop rapid sample prep to support chlamydia testing in low-resource settings.

NEW YORK (GenomeWeb News) – Quidel reported after the close of the market on Tuesday that its fourth quarter revenues declined 7 percent year over year on slower influenza and respiratory disease business.

Pages

The US Patent and Trademark Office is opening another interference proceeding in the CRISPR patent fight.

There's increasing genetic evidence that a number of ancient hominins may have contributed to the human gene pool, according to Discover's The Crux blog.

The Japan News writes that Japan needs to seize the opportunity to ensure that a wide number of people benefit from personalized cancer treatments.

In Cell this week: messenger RNA expression and translation, RNA localization atlas, and more.